InsiderClue
Insiders · Profile

Venrock Healthcare Capital Partners III, L.P.

10% owner at Oruka Therapeutics · 10% owner at Cogent Biosciences · 10% owner at Altimmune. Filing since 26 May 2020. CIK 0001738048

ORKA Oruka Therapeutics, Inc. 10% owner · 5 trades COGT Cogent Biosciences, Inc. 10% owner · 3 trades ALT Altimmune, Inc. 10% owner · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ORKA Oruka Therapeutics, Inc.
14 Feb 2025
10% owner
Bought
88,794
$1.02M
2.2%
ORKA Oruka Therapeutics, Inc.
13 Feb 2025
10% owner
Bought
14,950
$173.87K
0.4%
ORKA Oruka Therapeutics, Inc.
12 Feb 2025
10% owner
Bought
8,971
$106.40K
0.2%
ORKA Oruka Therapeutics, Inc.
11 Feb 2025
10% owner
Bought
9,593
$105.04K
0.2%
ORKA Oruka Therapeutics, Inc.
10 Feb 2025
10% owner
Bought
574
$6.26K
0.0%
COGT Cogent Biosciences, Inc.
18 Aug 2020
10% owner
Bought
101,000
$264.62K
2.4%
COGT Cogent Biosciences, Inc.
17 Aug 2020
10% owner
Bought
250,000
$642.50K
6.2%
COGT Cogent Biosciences, Inc.
14 Aug 2020
10% owner
Bought
100,000
$230.00K
2.6%
ALT Altimmune, Inc.
15 Jun 2020
10% owner
Bought
1,500,000
$11.31M
50.0%
ALT Altimmune, Inc.
28 May 2020
10% owner
Bought
201,474
$1.76M
7.2%
ALT Altimmune, Inc.
27 May 2020
10% owner
Bought
402,162
$3.10M
16.8%
ALT Altimmune, Inc.
26 May 2020
10% owner
Bought
700,000
$6.54M
41.3%
12 decisions on file.